A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2011
12/28/2011	CN102038745B 一种降血脂中药 One kind of cholesterol-lowering medicine
12/28/2011	CN102028811B 一种治疗消渴病的中药组合物 A therapeutic herbal composition Diabetes
12/28/2011	CN101978965B 一种药物在治疗糖尿病中的用途 A pharmaceutical use in the treatment of diabetes
12/28/2011	CN101953846B 一种药物组合物在制备治疗糖尿病的药物中的用途 A pharmaceutical composition in the manufacture of a medicament for treating diabetes use
12/28/2011	CN101912445B 一种表面活性剂辅助提取香椿叶中总黄酮的方法 A method of surfactant-assisted extraction of total flavonoids toon
12/28/2011	CN101912418B 一种速溶阿胶粉及其制备方法 A crumb of instant and its preparation method
12/28/2011	CN101904925B 一种治疗高脂血症的中药组合物 A method of treating hyperlipidemia herbal composition
12/28/2011	CN101879278B 一种具有降血糖作用的药物组合物及制备方法和用途 Having a hypoglycemic effect of pharmaceutical compositions and preparation and use
12/28/2011	CN101869680B 滋肾益精、补脑安神的组合物的新用途 New uses Kidney essence, brain nerves composition
12/28/2011	CN101792440B 喹唑啉酮衍生物及其制备和应用 Quinazolinone derivatives, preparation and application
12/28/2011	CN101759683B 二氢化茚酰胺化合物制备方法、包含其的药物组合物、及其作为蛋白激酶抑制剂的应用 Indane amide compound preparation, pharmaceutical compositions containing them, their use as protein kinase inhibitors
12/28/2011	CN101691410B 一种具有防治胰岛素抵抗作用的海洋寡糖铬配合物 Having a role in prevention and treatment of insulin resistance in marine oligosaccharides chromium complexes
12/28/2011	CN101679306B 治疗神经变性疾病的杂芳基酰胺取代的嘧啶酮衍生物 Treatment of neurodegenerative diseases heteroaryl amide substituted pyrimidone derivatives
12/28/2011	CN101643463B 6-甲基香豆素-7-磺酰脲类化合物及其合成方法 6-methyl-coumarin -7- sulfonylurea compounds and synthetic methods
12/28/2011	CN101618095B 大枣及山楂有效部位在降血脂及抗氧化活性药物方面应用 Jujube and hawthorn effective parts used in fat and antioxidant activity of drugs
12/28/2011	CN101611854B 富集转化桑叶的鸡腿菇及其栽培方法和用途 Conversion and enrichment Mushroom mulberry cultivation methods and uses
12/28/2011	CN101606936B 一种治疗糖尿病的药物组合物 A method of treating diabetes, the pharmaceutical compositions
12/28/2011	CN101549149B 一种新的降钙素的水溶液鼻用喷雾制剂 A new aqueous nasal spray formulation of calcitonin
12/28/2011	CN101531638B 用作雌激素相关受体调节剂的化合物及其应用 Compounds useful as modulators of estrogen-related receptor and Its Application
12/28/2011	CN101502541B 安息香属植物及其提取物的用途 Styrax uses of plants and their extracts
12/28/2011	CN101411813B 一种中药组合物在制备治疗慢性收缩性心力衰竭药物中的应用 Chinese medicinal composition for the preparation of the treatment of chronic systolic heart failure drug application
12/28/2011	CN101356980B 一种鱼肝脏水解物的制备方法及应用 A preparation method and application of fish liver hydrolyzate
12/28/2011	CN101274012B 夏枯草属植物提取物的组合物、制备方法及其药物用途 Prunella plant extract composition, preparation and pharmaceutical use
12/28/2011	CN101172140B 促进造血干细胞增殖与血红蛋白合成的营养组合物 Promote hematopoietic stem cell proliferation and synthesis of hemoglobin nutritional composition
12/28/2011	CN101057888B 一种调节免疫力的中药组合物及其制备方法和应用 An adjustment of Chinese medicine composition and preparation method and application of immunity
12/28/2011	CN101036646B 苦木总生物碱及其单体生物碱的医药用途 Wood bitter alkaloid monomers total alkaloids and medicinal use
12/27/2011	US8086277 Transmitter of wireless microphone, receiver for wireless microphone, portable information communication device, and wireless microphone communication system
12/27/2011	US8084645 4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors
12/27/2011	US8084605 Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
12/27/2011	US8084578 Monoclonal antibody against human scavenger receptor SRCL-P1
12/27/2011	US8084489 Glucagon receptor antagonists, preparation and therapeutic uses
12/27/2011	US8084488 Forms of [R-(R,R)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium
12/27/2011	US8084437 Methods for treating hypercholesterolemia
12/27/2011	US8084422 Method of treating insulin resistance with a selective inhibitor of CB2 receptor activity
12/27/2011	US8084413 Urocortin-III and uses thereof
12/27/2011	US8084256 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
12/27/2011	US8084253 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
12/27/2011	US8084049 Complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
12/27/2011	US8084031 Method for the treatment of inflammatory disorders
12/23/2011	CA2744428A1 Nutritional or dietary supplement composition and methods for using same for treating visual acuity loss
12/22/2011	WO2011160093A2 Methods and systems for modulating hormones and related methods, agents and compositions
12/22/2011	WO2011159917A2 Growth hormone secretatogue receptor antagonists and uses thereof
12/22/2011	WO2011159760A1 Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
12/22/2011	WO2011159634A1 Triheptanoin diet for adult polyglucosan body disease (apbd) treatment
12/22/2011	WO2011159067A2 Thiazole derivatives as sglt2 inhibitors and pharmaceutical composition comprising same
12/22/2011	WO2011158904A1 Therapeutic agent for inflammatory diseases containing adenosine n1-oxide as active ingredient
12/22/2011	WO2011158149A1 2-(3,5-disubstitutedphenyl)pyrimidin-4(3h)-one derivatives
12/22/2011	WO2011158052A1 Nanostructured ezetimibe compositions, process for the preparation thereof and pharmaceutical compositions containing them
12/22/2011	WO2011157682A1 3-oxo-3,9-dihydro-1h-chromeno[2,3-c]pyrroles as glucokinase activators
12/22/2011	WO2011157227A1 Compounds having activating effect on subtypes of peroxisome proliferator-activated receptors and its preparation method and uses
12/22/2011	WO2011100659A3 Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs
12/22/2011	WO2011094467A3 Methods of treating diabetes with dll4 antagonists
12/22/2011	WO2011051486A3 Pharmaceutical solution of non covalently bound albumin and acylated insulin
12/22/2011	US20110313055 Health characteristic chewy or gummy candy confection
12/22/2011	US20110313041 Food supplements on the basis of pantothenic acid
12/22/2011	US20110313039 Method for increasing endogenous plasmalogen levels in mammals
12/22/2011	US20110313024 RNA INTERFERENCE MEDIATED INHIBITION OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/22/2011	US20110313020 UsiRNA Complexes
12/22/2011	US20110313014 Products comprising n-phenylpropenoyl amino acid amides and uses thereof
12/22/2011	US20110313011 Amino Acid Compounds
12/22/2011	US20110313008 Pentafluorosulpholane-containing antidiabetic compounds
12/22/2011	US20110313007 Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
12/22/2011	US20110313003 Gpr120 receptor agonists and uses thereof
12/22/2011	US20110313002 Tricyclic compounds
12/22/2011	US20110313000 Ccr9 inhibitors and methods of use thereof
12/22/2011	US20110312995 Bridged and fused heterocyclic antidiabetic compounds
12/22/2011	US20110312989 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
12/22/2011	US20110312983 Deuterium-enriched alogliptin
12/22/2011	US20110312979 Fused pyrrole derivatives as pi3k inhibitors
12/22/2011	US20110312976 Novel isoindolin-1-one derivative
12/22/2011	US20110312975 Certain chemical entities, compositions and methods
12/22/2011	US20110312972 Substituted 3-benzofuranyl-indol-2-one-3-acetamididopiperazine derivatives, preparation thereof, and therapeutic use thereof
12/22/2011	US20110312971 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/22/2011	US20110312970 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia
12/22/2011	US20110312967 Bridged and fused antidiabetic compounds
12/22/2011	US20110312963 P38 map kinase inhibitors
12/22/2011	US20110312958 Modulators of atp-binding cassette transporters
12/22/2011	US20110312954 Mineralocorticoid receptor antagonist and methods of use
12/22/2011	US20110312952 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/22/2011	US20110312951 C-Ring Modified Tricyclic Benzonaphthiridinone Protein Kinase Inhibitors and Use Thereof
12/22/2011	US20110312950 CYCLIC INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
12/22/2011	US20110312949 Pharmaceutical use of substituted amides
12/22/2011	US20110312947 Method of improving ß-adrenergic receptor function
12/22/2011	US20110312946 Combination therapy for the treatment of diabetes
12/22/2011	US20110312945 Crth2 modulators
12/22/2011	US20110312941 1,4-disubstituted piperidines as vasopressin receptor via antagonists
12/22/2011	US20110312937 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
12/22/2011	US20110312936 Cyclohexyl-azetidinyl antagonists of ccr2
12/22/2011	US20110312935 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents
12/22/2011	US20110312931 Glycine transporter-1 inhibitors, methods of making them, and uses thereof
12/22/2011	US20110312930 Aryl compounds with aminoalkyl substituents and their use
12/22/2011	US20110312923 Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis
12/22/2011	US20110312921 N-Myristoyl Transferase Inhibitors
12/22/2011	US20110312920 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
12/22/2011	US20110312911 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
12/22/2011	US20110312904 Compounds, compositions and methods for reducing toxicity and treating or preventing diseases
12/22/2011	US20110312883 Neurturin molecules
12/22/2011	US20110312881 Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases
12/22/2011	US20110312878 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
12/22/2011	US20110312873 N-terminally modified tetrapeptide derivatives having a c-terminal arginine mimetic

1 ... 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 ... 1298